Olink

Olink®
Part of Thermo Fisher Scientific

A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Clinical Proteomics, 2015

Mahboob S., Ahn S., Cheruku H., Cantor D., Rennel E., Fredriksson S., Edfeldt G., Breen E., Khan A., Mohamedali A., Muktadir M., Ranganathan S., Tan S., Nice E., Baker M.

Disease areaApplication areaSample typeProducts
Oncology
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

Patients with Duke’s stage Colorectal Cancer (CRC) were analyzed using both Proseek Multiplex and Luminex (27-plex Bio-plex human cytokine panel. 13 proteins showed similar expression pattern between the two platforms, but Proseek Multiplex showed significant correlation between CEA, IL-8, prolactin and CRC stage.

Read publication ↗